Search Results

There are 14421 results for: content related to: Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: High-risk subgroups and time course of risk

  1. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain

    Acta Anaesthesiologica Scandinavica

    Volume 48, Issue 5, May 2004, Pages: 525–546, J. Rømsing and S. Møiniche

    Version of Record online : 21 APR 2004, DOI: 10.1111/j.0001-5172.2004.00379.x

  2. Rofecoxib for osteoarthritis

    Intervention Review

    The Cochrane Library

    Sarah E Garner, Dogan Fidan, Ruth R Frankish and Lara Maxwell

    Published Online : 24 JAN 2005, DOI: 10.1002/14651858.CD005115

  3. Single dose oral rofecoxib for acute postoperative pain in adults

    Intervention Review

    The Cochrane Library

    Simon Bulley, Sheena Derry, R Andrew Moore and Henry J McQuay

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD004604.pub3

  4. NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 12, December 2009, Pages: 1134–1142, Sebastian Schneeweiss, Robert J. Glynn, Jerry Avorn, Muhammad Mamdani, Helen Mogun and Daniel H. Solomon

    Version of Record online : 20 OCT 2009, DOI: 10.1002/pds.1826

  5. Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 6, June 2011, Pages: 855–866, F Salvo, A Fourrier-Réglat, F Bazin, P Robinson, N Riera-Guardia, M Haag, AP Caputi, N Moore, MC Sturkenboom, A Pariente and on behalf of investigators of the Safety of Non-Steroidal Anti-Inflammatory Drugs: The SOS Project

    Version of Record online : 6 APR 2011, DOI: 10.1038/clpt.2011.45

  6. You have free access to this content
    Arthritis & Rheumatism, 2001 Annual Scientific Meeting Abstracts, November 10–15, 2001, San Francisco, CA

    Arthritis & Rheumatism

    Volume 44, Issue S9, September 2001, Pages: 277–390,

    Version of Record online : 22 FEB 2002, DOI: 10.1002/1529-0131(200109)44:9+<::AID-ART427>3.0.CO;2-4

  7. You have free access to this content
    Defects in mouse nephrogenesis induced by selective and non-selective cyclooxygenase-2 inhibitors

    British Journal of Pharmacology

    Volume 163, Issue 5, July 2011, Pages: 927–936, Anke Olliges, Stefanie Wimmer and Rolf M Nüsing

    Version of Record online : 8 JUN 2011, DOI: 10.1111/j.1476-5381.2011.01313.x

  8. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk

    Internal Medicine Journal

    Volume 36, Issue 5, May 2006, Pages: 308–319, M. Hermann and F. Ruschitzka

    Version of Record online : 20 APR 2006, DOI: 10.1111/j.1445-5994.2006.01056.x

    Corrected by:


    Vol. 36, Issue 12, 799, Version of Record online: 9 NOV 2006

  9. You have free access to this content
    Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: Case study of cyclooxygenase 2–selective inhibitors for the treatment of osteoarthritis

    Arthritis Care & Research

    Volume 53, Issue 4, 15 August 2005, Pages: 510–518, Chin Lee, Elke Hunsche, Robert Balshaw, Sheldon X. Kong and Thomas J. Schnitzer

    Version of Record online : 4 AUG 2005, DOI: 10.1002/art.21328

  10. Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: A systematic review of randomized studies

    Acta Anaesthesiologica Scandinavica

    Volume 49, Issue 5, May 2005, Pages: 601–613, S. Straube, S. Derry, H. J. McQuay and R. A. Moore

    Version of Record online : 15 APR 2005, DOI: 10.1111/j.1399-6576.2005.00666.x

  11. The Cardiovascular Toxicity of Selective and Nonselective Cyclooxygenase Inhibitors: Comparisons, Contrasts, and Aspirin Confounding

    The Journal of Clinical Pharmacology

    Volume 45, Issue 7, July 2005, Pages: 742–750, Panagiotis A. Konstantinopoulos and David F. Lehmann

    Version of Record online : 25 MAR 2013, DOI: 10.1177/0091270005278202

  12. You have free access to this content
    Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease

    Intervention Review

    The Cochrane Library

    Xin-Pu Miao, Jian-Sheng Li, Qin Ouyang, Ren-Wei Hu, Yan Zhang and Hui-Yan Li

    Published Online : 23 OCT 2014, DOI: 10.1002/14651858.CD007744.pub2

  13. NSAIDs – COX-2 Inhibitors – Risks and Benefits

    Pharmacovigilance, Second Edition

    K. Arnold Chan, S. Christopher Jones, Pages: 583–602, 2007

    Published Online : 7 FEB 2007, DOI: 10.1002/9780470059210.ch47

  14. Risk of myocardial infarction associated with selective COX-2 inhibitors: Meta-analysis of randomised controlled trials

    Pharmacoepidemiology and Drug Safety

    Volume 16, Issue 7, July 2007, Pages: 762–772, Li-Chia Chen and Darren M Ashcroft

    Version of Record online : 25 APR 2007, DOI: 10.1002/pds.1409

  15. You have free access to this content
    The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 4, February 2003, Pages: 489–501, S. Alsalameh, M. Burian, G. Mahr, B. G. Woodcock and G. Geisslinger

    Version of Record online : 5 MAR 2003, DOI: 10.1046/j.1365-2036.2003.01460.x

  16. Cardiovascular Risks of Cyclooxygenase Inhibition

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 7, July 2006, Pages: 919–938, Dr. Zachary A. Stacy, Dr. Paul P. Dobesh and Dr. Toby C. Trujillo

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.7.919

  17. Making Progress in the Management of Postoperative Pain: A Review of the Cyclooxygenase 2–Specific Inhibitors

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 12, December 2004, Pages: 1714–1731, Dr. Jennifer M. Stephens, Dr. Chris L. Pashos, Ms. Seema Haider and Dr. Josephine M. Wong

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.17.1714.52339

  18. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events–stroke, acute myocardial infarction, and death from coronary heart disease

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 11, November 2009, Pages: 1053–1063, Christianne L. Roumie, Neesha N. Choma, Lisa Kaltenbach, Edward F. Mitchel, Jr, Patrick G. Arbogast and Marie R. Griffin

    Version of Record online : 27 JUL 2009, DOI: 10.1002/pds.1820

  19. You have free access to this content
    Impact of Rofecoxib Withdrawal on Cyclooxygenase-2 Utilization among Patients with and without Cardiovascular Risk

    Value in Health

    Volume 9, Issue 6, November/December 2006, Pages: 361–368, Patrick Thiebaud, Bimal V. Patel and Michael B. Nichol

    Version of Record online : 14 SEP 2006, DOI: 10.1111/j.1524-4733.2006.00128.x

  20. Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control

    Journal of Clinical Pharmacy and Therapeutics

    Volume 29, Issue 3, June 2004, Pages: 215–229, L.-C. Chen, R. A. Elliott and D. M. Ashcroft

    Version of Record online : 19 MAY 2004, DOI: 10.1111/j.1365-2710.2004.00558.x